SCHEMBL17150367

SCHEMBL17150367

O=c1[nH]nnc2c(C(F)(F)F)cccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.58
AR P10275 1/20 0.44
KDM4E B2RXH2 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HSD17B10 Q99714 1/20 0.41
AXL P30530 1/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
TNKS O95271 3/20 0.39
TNKS2 Q9H2K2 3/20 0.39
PARP2 Q9UGN5 2/20 0.39
NOTUM Q6P988 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NCF1 P14598 1/20 0.37
KIF11 P52732 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1841757 0.77 PARP1 (0.54) PARP1ARTNKSTNKS2PARP2
SCHEMBL1845203 0.77 PARP1 (0.54) PARP1ARHSD17B10ALDH1A1TNKS
SCHEMBL23301967 0.75 CACNA1H (0.37) PARP1
SCHEMBL29656854 0.75 CACNA1H (0.37) PARP1
SCHEMBL8022804 0.75 AXL (0.49) PARP1AXLALDH1A1MEN1POLB
SCHEMBL1843209 0.74 PARP1 (0.54) PARP1ARTNKSTNKS2
SCHEMBL17950598 0.74 PARP1 (0.42) PARP1KDM4EHSD17B10AXLALDH1A1
SCHEMBL1094731 0.73 PARP1 (1.00) PARP1KDM4ESMN1; SMN2HSD17B10ALDH1A1
SCHEMBL873985 0.73 TNKS (0.51) PARP1ARKDM4EHSD17B10ALDH1A1
SCHEMBL3507122 0.72 PARP1 (0.66) PARP1KDM4ESMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015150366-A1 CYCLICALLY SUBSTITUTED PHENOL ETHER DERIVATIVES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-10-08 WO disclosed